Sort
39,280 grants matching “leukemia”
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal Cancer
$506,666Jeffrey A Meyerhardt · Dana-Farber Cancer Inst · R01 · FY2011 · CA
A model of myelodysplastic syndrome progression and leukemic stem cells
$506,639Yupo Ma · State University New York Stony Brook · R01 · FY2010 · HL
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$506,551Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
UG1 - NCTN (Network Lead)
$506,534Hedy L Kindler · University Of Chicago · UG1 · FY2024 · CA
Targeting ABL kinases to regulate epithelial cell plasticity and regeneration following injury
$506,239Ann Marie Pendergast · Duke University · R01 · FY2020 · HL
Early Imaging Detection of CV Injury after Cancer
$506,158William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2015 · CA
Characterization of the LGL Leukemia Virus (PQ 12)
$506,096Thomas P Loughran · University Of Virginia · R01 · FY2013 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$506,088Kevin M Shannon · University Of California, San Francisco · R01 · FY2023 · CA
Selectively Targeting Oncogenic NRAS in Cancer
$506,084Kevin M Shannon · University Of California, San Francisco · R01 · FY2022 · CA
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$506,056Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
REGULATION OF HUMAN HEMATOPOIETIC STEM CELL FATE VIA MLLT3 ISOFORMS
$506,031Hanna Katri Annikki Mikkola · University Of California Los Angeles · R01 · FY2024 · DK
Mcl-1 in apoptosis and signal transduction: a structure/function approach
$505,956Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Illuminating molecular targetable pathways in HNSCC
$505,849Molly F. Kulesz-Martin · Oregon Health & Science University · R01 · FY2017 · CA
Illuminating molecular targetable pathways in HNSCC
$505,849Molly F. Kulesz-Martin · Oregon Health & Science University · R01 · FY2015 · CA
Targeting MicroRNAs to Eradicate Leukemia Stem Cells
$505,757Ya-Huei Kuo · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Inhibition of Bcl-xL by Targeted Degradation
$505,715Guangrong Zheng · University Of Florida · R01 · FY2021 · CA
Predictors of myelodysplastic syndrome in Minnesota
$505,659Jenny N. Poynter · University Of Minnesota · R01 · FY2014 · CA
Understanding critical transitions in chronic myeloid leukemia to improve tyrosine kinase inhibitor therapy
$505,549Richard A. Van Etten · University Of California-Irvine · P01 · FY2025 · CA
Engineering CAR T cells to Provide a Durable Control of HIV Replication
$505,417James L Riley · University Of Pennsylvania · P01 · FY2025 · AI
Clinical, Immunological and Genetic Analyses of ALPS
$505,345Vemulkonda Rao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
REGULATION OF NEUTROPHIL-SPECIFIC GENE EXPRESSIONS
$505,307Nancy Berliner · Yale University · P01 · FY2007 · HL
UG1 - NCTN (Network Lead)
$505,218Hedy L Kindler · University Of Chicago · UG1 · FY2019 · CA
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
$505,206Joseph M Ready · Ut Southwestern Medical Center · R01 · FY2018 · CA
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$505,143Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2020 · AI
Next Generation gene discovery in neurogenetics
$505,104Wendy H Raskind · University Of Washington · R01 · FY2017 · NS